The Bronx, NY2 Active Studies

Chronic Kidney Disease Clinical Trials in The Bronx, NY

Find 2 actively recruiting chronic kidney disease clinical trials in The Bronx, NY. Connect with local research sites and explore new treatment options.

2
Active Trials
2
Sponsors
263
Enrolling

Recruiting Chronic Kidney Disease Studies in The Bronx

About Chronic Kidney Disease Clinical Trials in The Bronx

Chronic kidney disease (CKD) is a progressive loss of kidney function over months or years. It affects about 10% of the global population and can lead to end-stage renal disease requiring dialysis or transplant. Management includes controlling blood pressure, blood sugar, and using newer agents like SGLT2 inhibitors.

There are currently 2 chronic kidney disease clinical trials recruiting participants in The Bronx, NY. These studies are seeking a combined 263 participants. Research is being sponsored by University of California, Los Angeles, Albert Einstein College of Medicine. Clinical trial participation is free and participants receive study-related medical care at no cost.

Chronic Kidney Disease Clinical Trials in The Bronx — FAQ

Are there chronic kidney disease clinical trials in The Bronx?

Yes, there are 2 chronic kidney disease clinical trials currently recruiting in The Bronx, NY. Browse the studies on this page to find one that fits.

How do I join a clinical trial in The Bronx?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the The Bronx research site will contact you about next steps.

Are clinical trials in The Bronx free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many The Bronx studies also compensate for your time and travel.

What chronic kidney disease treatments are being tested?

The 2 active trials in The Bronx are testing new therapies including novel drugs, biologics, and treatment approaches for chronic kidney disease.

Data updated March 2, 2026 from ClinicalTrials.gov